On Monday, the Centers for Medicare & Medicaid Services (CMS) proposed removing the coverage with evidence development (CED) requirement for Transcatheter Aortic Valve Replacement (TAVR) in patients with symptomatic severe aortic stenosis.
William Blair on Tuesday wrote, "…this is a positive outcome for Edwards and largely validates the thesis we laid out following the NCD opening in December."
CMS Proposes Changes To TAVR Coverage Requirements
Aortic stenosis is a narrowing or stiffening of the heart's aortic valve. It restricts blood flow from the heart's main pumping chamber to the rest of the body.
Read Next
